This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Istubal, Valodex, tamoxifen citrate
Description: Nolvadex (tamoxifen citrate) is an oral anti-oestrogen for breast cancer.
Tamoxifen was originally developed by ICI Pharmaceuticals.
In 1993, ICI divested its pharmaceutical business to Zeneca Group, which subsequently merged with Astra AB to form AstraZeneca PLC.
Pink Sheet Roche/Zeneca Nolvadex agreement
Additional information available to subscribers only: